EUVIMEDEUVIMED entdecken
Crossref

Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy

S M Hussein, N K Zaidan

Biomeditsinskaya Khimiya · 2026-07 · 72 (3) · 230-235

DOI: 10.18097/pbmce0047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomeditsinskaya Khimiya, 2026. Verfasst von S M Hussein und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Fallujah, College of Applied Sciences, Fallujah, Iraq. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metformin, Adiponectin, Leptin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder, which is commonly related to reduced insulin responsiveness and altered appetite-related hormones. In this study, we have evaluated how combined metformin and sulfonylurea therapy affects glycemic indicators and appetite hormones, with special focus on hormone ratios. Sixty participants were involved in the study: 30 diabetic patients receiving combined metformin-sulfonylurea therapy and 30 conditionally healthy individuals serving as controls. Fasting blood samples were collected to assess indicators of glycemic control, lipid profiles, and hormone levels using standard biochemical assays and ELISA. The patient group showed clear increases in fasting glucose, HbA1c, insulin, insulin resistance indices, lipid profile measurements, and leptin levels, whereas the levels of HDL, ghrelin, and adiponectin were markedly decreased compared with the control group (p < 0.001). The results of the study show that T2DM patients continue to have both insulin resistance and poor blood glucose control despite combined metformin-sulfonylurea therapy. Alterations in appetite hormones also reflect underlying metabolic dysregulation, and hormonal ratios, especially the leptin/adiponectin ratio, are more accurate indicators of this imbalance than individual hormone measurements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MetforminAdiponectinLeptinGhrelinInsulinSulfonylurea CompoundsHypoglycemic AgentsHumansFemaleMaleMiddle AgedInsulin ResistanceBlood GlucoseDrug Therapy, CombinationAdultGlycated Hemoglobin

Stichwörter der Autor:innen

adiponectinghrelininsulinleptinmetforminsulfonylurea

Substanzen

MetforminAdiponectinLeptinGhrelinInsulinSulfonylurea CompoundsADIPOQ protein, humanHypoglycemic AgentsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • University of Fallujah, College of Applied Sciences, Fallujah, Iraq.

Zitieren

APA

Hussein, S. M., & Zaidan, N. K. (2026). Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy. Biomeditsinskaya Khimiya, 72(3), 230-235. https://doi.org/10.18097/pbmce0047

Vancouver

Hussein SM, Zaidan NK. Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy. Biomeditsinskaya Khimiya. 2026;72(3):230-235. doi:10.18097/pbmce0047

BibTeX
@article{Hussein2026,
  author = {Hussein, S M and Zaidan, N K},
  title = {Evaluation of insulin, leptin, ghrelin, and adiponectin levels in type 2 diabetic patients receiving combined metformin-sulfonylurea therapy},
  journal = {Biomeditsinskaya Khimiya},
  year = {2026},
  volume = {72},
  number = {3},
  pages = {230--235},
  doi = {10.18097/pbmce0047}
}
Kostenlos starten →